Human TLR9 Reporter HEK293 Cells
HEK-Blue™ hTLR9 cells | Unit size | Cat. code | Docs | Qty | Price |
---|---|---|---|---|---|
Human TLR9-expressing HEK293 cells |
3-7 x 10e6 cells |
hkb-htlr9 |
You may also need : HEK-Blue™ Null1 Cells | View more associated products ▼
Notification: This product is for internal research use only. Additional rights may be available. Please visit InvivoGen’s Terms and Conditions.
SEAP reporter system in HEK-Blue™ TLR9 cells
SEAP reporter 293 cells expressing the human TLR9 gene
InvivoGen also offers:
• HEK-Blue™ mTLR9 cells
• HEK-Dual™ hTLR9 cells
• TLR9 ligands - Including stimulatory and inhibitory ODNs, as well as bacterial DNA
InvivoGen offers a human embryonic kidney 293 (HEK293)-derived cell line, specifically designed for the study of human TLR9 (Toll-Like Receptor 9)-induced NF-κB signaling pathway:
• HEK-Blue™ hTLR9 cells
HEK-Blue™ hTLR9 cells overexpress the human TLR9 (hTLR9) gene. They also express a SEAP (secreted embryonic alkaline phosphatase) reporter gene under the control of an NF-κB inducible promoter comprised of an IFN-β minimal promoter fused to five NF-κB and AP-1 binding sites. Levels of SEAP in the supernatant can be easily determined with HEK-Blue™ Detection, a cell culture medium that allows real-time detection of SEAP activity.
Unlike their parental cells, HEK-Blue™ Null1, which weakly express TLR9, HEK-Blue™ hTLR9 cells are responsive to stimulation with TLR9 agonists, such as oligonucleotides containing CpG motifs (CpG ODNs). As expected, hTLR9 overexpression in HEK-Blue™ hTLR9 cells allows potent NF-κB responses upon incubation with human-preferred, but not mouse-preferred, CpG-ODNs of class A (e.g. ODN 2216) and class B (e.g. ODN 2006). Of note, HEK-Blue™ hTLR9 cells are more responsive to the class B, human-preferred, ODN 2006. These cells also respond to ODN 2395, a human/mouse-preferred class C (see Figures).
Background:
Toll-Like Receptor 9 (TLR9) is one of the most studied pattern recognition receptors (PRRs) for nucleic acids. It is an endosomal receptor that triggers NF-κB- and IRF-mediated pro-inflammatory responses upon the recognition of unmethylated cytosine-phosphorothioate-guanosine (CpG) forms of DNA [1-3]. TLR9 agonists can be mimicked by synthetic oligonucleotides containing CpG motifs (CpG ODNs) [1,3].
Key features:
- Verified overexpression of TLR9 gene by RT-PCR
- Functionally validated with a selection of TLR9 agonists
- Readily assessable SEAP reporter activity
Applications:
- Study of the NF-κB-dependent TLR9 signaling pathway
- Screening of novel specific activators or inhibitors of the TLR9 signaling pathway
References
1. Kumagai Y. et al., 2008. TLR9 as a key receptor of the recognition of DNA. Adv. Drug. Deliv. Rev. 60(7):795-804.
2. Heinz L.X. et al., 2021. TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9. Nature. 581(7808):316-322.
3. Kayraklioglu N. et al., 2021. CpG oligonucleotides as vaccine adjuvants. DNA Vaccines: Methods and Protocols. Methods in Molecular Biology. Vol. 2197. p51-77.
Specifications
Growth medium: DMEM, 4.5 g/l glucose, 2 mM L-glutamine, 10% (v/v) fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin, 100 μg/ml Normocin™.
Antibiotic resistance: Blasticidin, Zeocin®
Quality Control:
- Human TLR9 expression has been verified by RT-PCR and functional assays.
- The stability for 20 passages, following thawing, has been verified.
- These cells are guaranteed mycoplasma-free.
InvivoGen's products are covered by a Limited Use License (See Terms and Conditions).
Back to the topContents
- 3-7 x 106 HEK-Blue™ hTLR9 cells in a cryovial or shipping flask
- 1 ml of Blasticidin (10 mg/ml)
- 1 ml of Zeocin® (100 mg/ml)
- 1 ml of Normocin™ (50 mg/ml)
- 1 pouch of HEK-Blue™ Detection (cell culture medium for real-time detection of SEAP)
Shipped on dry ice (Europe, USA, Canada, and some areas in Asia)
Details
Toll-Like Receptor 9 (TLR9) is an endosomal receptor that triggers NF-κB- and IRF-mediated pro-inflammatory responses upon the recognition of unmethylated cytosine-phosphorothioate-guanosine (CpG) forms of DNA [1-3]. Unmethylated CpG dinucleotides are a hallmark of microbial (bacterial, viral, fungal, and parasite) DNA, as well as mitochondrial self-DNA [3,4]. These TLR9 agonists can be mimicked by synthetic oligonucleotides containing CpG motifs (CpG ODNs), which have been extensively studied to improve adaptive immune responses in the context of vaccination [1,3].
TLR9 is mainly expressed in subsets of Dendritic Cells and in B cells of all mammals. In rodents, but not in humans, TLR9 is also expressed in monocytes and macrophages [3]. The structure of the receptor varies by 24% between human TLR9 (hTLR9) and mouse TLR9 (mTLR9) [3]. They recognize different CpG motifs, the optimal sequences being GTCGTT and GACGTT for hTLR9 and mTLR9, respectively [5].
Get more information about CpG-ODNs Classes.
References
1. Kumagai Y. et al., 2008. TLR9 as a key receptor of the recognition of DNA. Adv. Drug. Deliv. Rev. 60(7):795-804.
2. Heinz L.X. et al., 2021. TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9. Nature. 581(7808):316-322.
3. Kayraklioglu N. et al., 2021. CpG oligonucleotides as vaccine adjuvants. DNA Vaccines: Methods and Protocols. Methods in Molecular Biology. Vol. 2197. p51-77.
4. Kumar V., 2021. The trinity of cGAS, TLR9, and ALRs: guardians of the cellular galaxy against host-derived self-DNA. Front. Immunol. 11:624597.
5. Bauer S. et al., 2001. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA, 98(16):9237-42.